Evidence map›Paper›PMID 36145560›Full record

ArticlePharmaceutics2022

Design, Formulation, and Evaluation of

Narayana Charyulu Rompicherla, Punam Joshi, Amitha Shetty, Kalvatala Sudhakar, Hawraz Ibrahim M Amin, Yachana Mishra, Vijay Mishra, Aqel Albutti, Naif Alhumeed

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Gels (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Narayana Charyulu RompicherlaDepartment of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to Be University), Mangaluru 575018, Karnataka, India.
Punam JoshiDepartment of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to Be University), Mangaluru 575018, Karnataka, India.
Amitha ShettyDepartment of Pharmaceutics, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to Be University), Mangaluru 575018, Karnataka, India.ORCID 0000-0002-7723-3668
Kalvatala SudhakarSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0002-1123-9864
Hawraz Ibrahim M AminDepartment of Chemistry, College of Science, Salahaddin University-Erbil, Erbil 44001, Iraq.ORCID 0000-0002-0561-4365
Yachana MishraDepartment of Zoology, School of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0002-3467-0518
Vijay MishraSchool of Pharmaceutical Sciences, Lovely Professional University, Phagwara 144411, Punjab, India.ORCID 0000-0001-6542-2464
Aqel AlbuttiDepartment of Medical Biotechnology, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.ORCID 0000-0001-8697-5340
Naif AlhumeedDeputyship for Research and Innovation, Ministry of Education, Riyadh 11153, Saudi Arabia.
Lovely Professional University · INNitte University · INCihan University-Erbil · IQMinistry of Education · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Topical treatments are a potential therapeutic option for the therapy of osteoarthritis, with significant data supporting the effectiveness and safety of topical formulation. Topical gel formulations may offer an alternative to oral formulations to relieve osteoarthritis (OA) pain while decreasing systemic exposure. Topical capsaicin transemulgel may represent an effective and safe alternative. The transemulgel was prepared from aqueous

Indexed as

anti-inflammatory agentarthritiscapsaicindrug deliveryemulsiontopical

Identifiers

PMID36145560
PMCPMC9503439
OpenAlexW4293769797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.